Silica-based core-shell structures (C’ dots), when surface-modified with melanoma-targeting MC1-R peptides, demonstrate significantly improved pharmacokinetics: C’ dots with sizes below 10 nm enable renal clearance, reduce hepatic accumulation, and enhance tumor uptake by 4.8-fold compared to free peptides [15]. This evidence concerns the gene MC1R and melanoma.